ResMed | RMD - Cost Of Sales



ResMed reported $518.56M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Ansell USD 254.1M 232.2M Jun/2024
Avita Medical AUD 2.28M 170K Dec/2024
Cochlear AUD 290.1M 20.2M Dec/2024
CSL USD 3.93B 527M Dec/2024
Fisher & Paykel Healthcare NZD 387.6M 25.1M Mar/2025
Healius AUD 107.9M 201.85M Dec/2024
Integral Diagnostics AUD 11.53M 146K Jun/2024
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Nanosonics AUD 20.15M 9.46M Dec/2024
Polynovo AUD 4.77M 2.77M Jun/2024
Ramsay Health Care AUD 2.23B 6.3M Dec/2024
ResMed USD 518.56M 12.25M Jun/2025
Sigma Healthcare AUD 1.72B 188.07M Jul/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024